Jobs / United States / Glaxosmithkline LLC
Global Data Generation GI Oncology Franchise Head
Glaxosmithkline LLC · 🇺🇸 2 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles1 certified filing for “Sr Manager - Oncology Commercial Analytics, Multiple Myeloma” (Data Scientists) in PA: $135k–$135k, median $135k. Most were filed at wage level III (100%) — 3 lottery entries, ≈46% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
Position Summary As Global Data Generation GI Oncology Franchise Head, you will oversee Data Generation for the overall GSK oncology portfolio and be directly responsible for delivering all Real World Evidence and non-interventional studies. You will design and oversee evidence generation plans that support clinical and access decisions across the product lifecycle. You will work closely with Medical Affairs, Clinical Development, Market Access, Commercial, and external partners. We value clear scientific thinking, collaborative leadership, and the ability to translate evidence into practical actions that improve patient care. This role offers growth, visible impact, and alignment with GSK’s mission of uniting science, technology and talent to get ahead of disease together. Responsibilities This role will provide YOU the opportunity to lead key activities to progress YOUR career. These responsibilities include some of the following: • Work in partnership with the Global Medical Franchise Head to develop the overall data generation plans that align clinical, regulatory and access needs across the product lifecycle for all assets in the franchise. • Oversee integrated evidence generation across all assets in the franchise and lead evidence generation for the flagship asset while providing strategic direction and oversight for other assets within the franchise. • Oversee delivery of non-interventional studies, including protocol development, study execution, analysis and transparent reporting. • Lead and mentor the Data Generation team responsible for real-world evidence including health economic studies and outcomes research. • Partner with clinical development and medical teams to shape study design, endpoints and comparators to meet payer and HTA expectations. • Represent the team in cross-functional governance and in external scientific dialogue with payers, HTA bodies and academic partners. • Manage resource planning and budget for all evidence activities and track impact of evidence on internal decision-making and external access outcomes. Why You? Basic Qualifications: We are seeking professionals with the following required skills and qualifications to help us achieve our goals: • Advanced degree (PhD, PharmD, or Master’s) in health outcomes, health economics, epidemiology, biostatistics, clinical research, pharmacy, medicine, or related discipline. • 7 + years of experience in health outcomes, real-world evidence, health economics or related functions within the pharmaceutical or healthcare sector. • Hands-on experience with observational study design, comparative effectiveness, economic modeling, or advanced analytical methods. • Experience designing and delivering evidence generation plans to support commercialization, reimbursement, market access or regulatory submissions. • A track record of scientific publications or presentations at major congresses. • Experience leading cross-functional teams and influencing stakeholders across clinical, medical, commercial and access functions. • Strong project management skills with experience managing multiple studies and external partners. • Experience in direct line management. • Excellent written and verbal communication skills with the ability to present complex evidence clearly to diverse audiences. Preferred Qualifications: If you have the following characteristics, it would be a plus: • Experience leading teams in oncology or another complex therapy area. • Deep knowledge of the US and Global payer and HTA landscape, and familiarity with evidence requirements of major payers and value assessment organizations. • Experience building strategic external collaborations with academic groups, data custodians, or large provider systems. Locatio